Advisor Group Holdings, Inc. Abb Vie Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 545,967 shares of ABBV stock, worth $96.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

545,967

Previous 585,102 6.69%

Holding current value

$96.6 Million

Previous $100 Million 7.43%

% of portfolio

0.26%

Previous 0.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $6.41 Million - $7.8 Million	-39,135 Reduced 6.69%	545,967 $108 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $8.13 Million - $9.49 Million	-52,513 Reduced 8.24%	585,102 $100 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $45.7 Million - $52.1 Million	-286,077 Reduced 30.97%	637,615 $116 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $39.2 Million - $44.1 Million	-284,843 Reduced 23.57%	923,692 $143 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $31.3 Million - $36.2 Million	234,179 Added 24.03%	1,208,535 $180 Million
Q2 2023 Aug 21, 2023	SELL	$132.51 - $164.9 $71.3 Million - $88.7 Million	-537,861 Reduced 35.57%	974,356 $131 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $63.6 Million - $79.2 Million	480,034 Added 46.51%	1,512,217 $204 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $63,628 - $73,277	-440 Reduced 0.04%	1,032,183 $164 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $6.93 Million - $8.32 Million	50,137 Added 5.1%	1,032,623 $167 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $5.84 Million - $6.7 Million	43,508 Added 4.63%	982,486 $132 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $6.4 Million - $8.14 Million	-46,507 Reduced 4.72%	938,978 $144 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $182,792 - $226,793	-1,385 Reduced 0.14%	985,485 $151 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $5.28 Million - $6 Million	49,650 Added 5.3%	986,870 $107 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $3.91 Million - $4.35 Million	37,128 Added 4.12%	937,220 $106 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $6.97 Million - $7.68 Million	68,155 Added 8.19%	900,092 $97.5 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $3.61 Million - $4.88 Million	44,911 Added 5.71%	831,937 $89.2 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $825,681 - $969,077	-9,611 Reduced 1.21%	787,026 $69.2 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $119 Million - $160 Million	-1,628,578 Reduced 67.15%	796,637 $78.2 Million
Q1 2020 May 18, 2020	BUY	$64.5 - $97.79 $156 Million - $237 Million	2,425,215 New	2,425,215 $57.3 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Abb Vie Inc. Transaction History